THE ROLE OF PHARMACEUTICAL HEALTH EDUCATION IN HIV PREVENTION: AN INTEGRATIVE REVIEW ON ACCESS AND ADHERENCE TO PREP AND PEP
DOI:
https://doi.org/10.61164/tjd9b058Keywords:
HIV, PrEP, PEP, Health Education, Pharmaceutical Practice, PreventionAbstract
The human immunodeficiency virus (HIV) remains one of the major global public health challenges. Strategies such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) play a key role in prevention, especially among vulnerable populations. In this context, pharmaceutical health education stands out as an essential tool to promote access, adherence, and correct use of these prophylaxis strategies. This study aims to analyze, through an integrative review, the impact of the pharmacist's role in promoting health education focused on HIV prevention, emphasizing the strengthening of adherence to PrEP and PEP. The study investigated barriers, facilitators, and successful practices related to the pharmacist’s work in counseling and monitoring users. The results show that the presence of a qualified pharmacist significantly contributes to expanding access and increasing the effectiveness of prevention strategies, highlighting the importance of health education in the fight against HIV.
Downloads
References
BARRETO, J. L. et al. O farmacêutico como agente de cuidado na prevenção ao HIV: uma revisão de práticas clínicas. Revista Brasileira de Ciências Farmacêuticas, São Paulo, v. 57, n. 2, p. 234-242, 2021.
BRASIL. Ministério da Saúde. Boletim epidemiológico HIV/AIDS. Brasília, DF: Ministério da Saúde, 2019.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Manual técnico para diagnóstico da infecção pelo HIV em adultos e crianças. Brasília, DF: Ministério da Saúde, 2022.
CHEN, J. M. et al. Barriers and facilitators of pharmacist-provided PrEP care among high-risk populations in British Columbia, Canada. International Journal of STD & AIDS, London, v. 31, n. 12, p. 1162–1170, 2020.
CHIESA, P. et al. Profilaxia pré-exposição (PrEP) e as prevenções combinadas para redução da epidemia do HIV no Brasil: revisão integrativa / Pre-exposure prophylaxis (PrEP) and combined preventions for reducing the HIV epidemic in Brazil. Brazilian Journal of Development, Curitiba, v. 8, n. 5, p. 39075–39088, 2022. DOI: 10.34117/bjdv8n5-414. DOI: https://doi.org/10.34117/bjdv8n5-414
COSTA, J. M.; BARROS, D. F. Educação em saúde e prevenção das ISTs: desafios e possibilidades nas unidades de saúde. Saúde & Transformação Social, São Paulo, v. 11, n. 3, p. 40-47, 2020.
GARCIA, J. et al. Acceptability of pharmacist-initiated Post-Exposure Prophylaxis (PEP) for HIV: perspectives of users and physicians in Spain. AIDS Care, London, v. 33, n. 5, p. 627-634, 2021.
JONES, A. L. et al. High rates of adherence to Post-Exposure Prophylaxis (PEP) dispensed in community pharmacy settings. Journal of Acquired Immune Deficiency Syndromes, Hagerstown, v. 87, n. 5, p. e37-e40, 2021.
LIMA, R. A.; GUIMARÃES, F. F.; COSTA, P. K. Protocolo de cuidado farmacêutico e educação em saúde para adesão à PrEP em Unidades Básicas de Saúde: relato de experiência. Revista Brasileira de Farmácia Clínica e Ciências Farmacêuticas, São Paulo, v. 9, n. 3, p. 280-285, 2022.
MENDES, K. D. S.; SILVEIRA, R. C. C. P.; GALVÃO, C. M. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto — Enfermagem, Florianópolis, v. 17, n. 4, p. 758–764, out./dez. 2008. DOI: 10.1590/S0104-07072008000400018. Nota: Duas entradas repetidas (Mendes et al. 2008) e uma em inglês (Mendes et al. review) foram condensadas nesta entrada. DOI: https://doi.org/10.1590/S0104-07072008000400018
MINISTÉRIO DA SAÚDE. Boletim Epidemiológico HIV/AIDS 2022. Brasília, DF: Ministério da Saúde, 2022.
MOTA, E. R. et al. Use of post-exposure prophylaxis for HIV in young people: an integrative review. Revista Rene, Fortaleza, v. 23, e78152, 2022. DOI: 10.15253/2175-6783.20222378152. DOI: https://doi.org/10.15253/2175-6783.20222378152
OLIVEIRA, M. C. B. de; SANTOS, N. S. Profilaxia Pré-Exposição ao HIV no Brasil. Revista Brasileira de Educação e Saúde, João Pessoa, v. 10, n. 3, p. 92–99, 2020. DOI: 10.18378/rebes.v10i3.7863.
OLIVEIRA, R. M. et al. Impacto da atuação farmacêutica clínica na adesão ao tratamento antirretroviral. Revista de Saúde Pública, São Paulo, v. 54, n. 101, p. 1-9, 2020.
PRISMA. Preferred Reporting Items for Systematic Reviews and Meta-Analyses. [S. l.: s. n.]. Nota: Referência de fonte genérica, sem autoria, data ou local definidos no texto original, formatada como "Documento".
SILVA, A. P. C. et al. Contribuições da educação em saúde na prevenção ao HIV: reflexões sobre a prática farmacêutica. Cadernos de Saúde Pública, Rio de Janeiro, v. 37, n. 9, e00234420, 2021.
SILVA, J. C. F.; GORSKI, J. B.; BESSON, J. C. F. Pre-exposure prophylaxis (PrEP) to HIV: a literature review. Research, Society and Development, São Paulo, v. 12, n. 6, 2023. DOI: 10.33448/rsd-v12i6.41869. DOI: https://doi.org/10.33448/rsd-v12i6.41869
SILVA, J. C.; ALMEIDA, J. A.; MARQUEZ, C. O. Pharmaceutical assistance to patients with HIV/AIDS in Brazil: An integrative review. Research, Society and Development, São Paulo, v. 11, n. 8, e37011830966, 2022. DOI: 10.33448/rsd-v11i8.30966. DOI: https://doi.org/10.33448/rsd-v11i8.30966
SILVA, M. C. C.; OLIVEIRA, S. F. Competências farmacêuticas e o monitoramento clínico na profilaxia pré-exposição ao HIV: uma revisão narrativa. Saúde em Debate, Rio de Janeiro, v. 43, n. 123, p. 1018-1030, 2019.
SMITH, B. R. et al. Impact of pharmacist prescribing on PrEP initiation and retention in rural California counties. JAMA Network Open, Chicago, v. 6, n. 1, e2250212, 2023.
SOUSA, L. R. M. et al. Knowledge of PEP and PrEP among people living with HIV/AIDS in Brazil. BMC Public Health, London, v. 21, n. 64, 2021. DOI: 10.1186/s12889-020-10135-3. DOI: https://doi.org/10.1186/s12889-020-10135-3
SOUZA, L. M. et al. Prevenção combinada do HIV e a atuação do farmacêutico nas populações vulneráveis. Revista Pan-Amazônica de Saúde, Ananindeua, v. 13, e2022204, 2022.
UNAIDS. Global HIV & AIDS statistics — Fact sheet 2023. [Geneva]: UNAIDS. Disponível em: https://www.unaids.org. Acesso em: 1 mar. 2025. Nota: A ABNT 6023 (2023) utiliza "Disponível em:" e "Acesso em:".
WILLIAMS, L. J. et al. Telepharmacy support for daily PrEP adherence and retention: a prospective cohort study. Clinical Infectious Diseases, New York, v. 76, n. 1, p. 120–128, 2023.
Z, M. A. et al. Oferta de PEP por farmacêuticos: eficácia e segurança em ambiente de atenção primária. The Lancet Regional Health – Americas, Amsterdam, v. X, n. Y, p. ZZZ-ZZZ, 2021. Nota: Dados incompletos ("X", "Y", "ZZZ-ZZZ") foram mantidos conforme o original.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 José Nickolas dos Santos Valentim, Carla Islene de Holanda Moreira Coelho , Anuska Rhévia Lacerda Pontes, José Guilherme Ferreira Marques Galvão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
